Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,902
archived clinical trials in
Irritable Bowel Syndrome (IBS)

LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated:  10/3/2012
Long Island Clinical Research Associates
mi
from
Great Neck, NY
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Long Island Clinical Research Associates
mi
from
Great Neck, NY
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated:  10/3/2012
New York Center for Clinical Research
mi
from
Lake Success, NY
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
New York Center for Clinical Research
mi
from
Lake Success, NY
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated:  10/3/2012
Concorde Medical Group
mi
from
New York, NY
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Concorde Medical Group
mi
from
New York, NY
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated:  10/3/2012
NY Center for Women's Health Research
mi
from
New York, NY
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
NY Center for Women's Health Research
mi
from
New York, NY
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated:  10/3/2012
Asheville Gastroenterology Associates, P.A.
mi
from
Asheville, NC
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Asheville Gastroenterology Associates, P.A.
mi
from
Asheville, NC
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated:  10/3/2012
Carolina Digestive Diseases
mi
from
Greenville, NC
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Carolina Digestive Diseases
mi
from
Greenville, NC
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated:  10/3/2012
Carolinas Research Associates
mi
from
1, Charlotte, NC
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Carolinas Research Associates
mi
from
1, Charlotte, NC
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated:  10/3/2012
Wake Research Associates
mi
from
Meredith, NC
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Wake Research Associates
mi
from
Meredith, NC
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated:  10/3/2012
Consultants for Clinical Research of Cincinnati
mi
from
Cincinnati, OH
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Consultants for Clinical Research of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated:  10/3/2012
Gastroenterology Research Consultants of Greater Cincinnati
mi
from
Cincinnati, OH
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Gastroenterology Research Consultants of Greater Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated:  10/3/2012
Great Lakes Gastroenterology
mi
from
Mentor, OH
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Great Lakes Gastroenterology
mi
from
Mentor, OH
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated:  10/3/2012
Gastroenterology United of Tulsa
mi
from
Tulsa, OK
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Gastroenterology United of Tulsa
mi
from
Tulsa, OK
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated:  10/3/2012
The Orgeon Clinic - West Hills Gastroenterology
mi
from
Portland, OR
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
The Orgeon Clinic - West Hills Gastroenterology
mi
from
Portland, OR
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated:  10/3/2012
Pennsylvania Research Institute
mi
from
Bensalem, PA
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Pennsylvania Research Institute
mi
from
Bensalem, PA
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated:  10/3/2012
Research Across America
mi
from
Reading, PA
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Research Across America
mi
from
Reading, PA
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated:  10/3/2012
Anderson Gastroenterology Associates, LLC
mi
from
Anderson, SC
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Anderson Gastroenterology Associates, LLC
mi
from
Anderson, SC
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated:  10/3/2012
Franklin Gastroenterology
mi
from
Franklin, TN
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Franklin Gastroenterology
mi
from
Franklin, TN
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated:  10/3/2012
HCCA Clinical Research Solutions
mi
from
Jackson, TN
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
HCCA Clinical Research Solutions
mi
from
Jackson, TN
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated:  10/3/2012
Murfreesboro Medical Clinic
mi
from
Murfreesboro, TN
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Murfreesboro Medical Clinic
mi
from
Murfreesboro, TN
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated:  10/3/2012
Academy of Clinical Research
mi
from
Arlington, TX
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Academy of Clinical Research
mi
from
Arlington, TX
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated:  10/3/2012
ARAYVAN Clinical Research
mi
from
Arlington, TX
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
ARAYVAN Clinical Research
mi
from
Arlington, TX
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated:  10/3/2012
Austin Center for Clinical Research
mi
from
Austin, TX
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Austin Center for Clinical Research
mi
from
Austin, TX
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated:  10/3/2012
Trinity Clinical Research
mi
from
Carrollton, TX
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Trinity Clinical Research
mi
from
Carrollton, TX
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated:  10/3/2012
Digestive Health Center
mi
from
Pasadena, TX
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Digestive Health Center
mi
from
Pasadena, TX
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated:  10/3/2012
Spring Gastroenterology
mi
from
Spring, TX
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Spring Gastroenterology
mi
from
Spring, TX
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated:  10/3/2012
Granger Medical Clinic
mi
from
West Valley, UT
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Granger Medical Clinic
mi
from
West Valley, UT
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated:  10/3/2012
Gastroenterology Associates of Tidewater
mi
from
Chesapeake, VA
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Gastroenterology Associates of Tidewater
mi
from
Chesapeake, VA
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated:  10/3/2012
Digestive and Liver Disease Specialists
mi
from
Norfolk, VA
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Digestive and Liver Disease Specialists
mi
from
Norfolk, VA
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated:  10/3/2012
Advanced Gastroenterology
mi
from
Vancouver, WA
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Advanced Gastroenterology
mi
from
Vancouver, WA
Click here to add this to my saved trials
The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer
The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer
Status: Enrolling
Updated:  11/29/2012
M.D. Anderson Cancer Center
mi
from
Houston, TX
The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer
The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer
Status: Enrolling
Updated: 11/29/2012
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
North Alabama Research Center, LLC
mi
from
Athens, AL
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
North Alabama Research Center, LLC
mi
from
Athens, AL
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Alliance Clinical Research
mi
from
Birmingham, AL
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Alliance Clinical Research
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Greystone Medical Research, LLC
mi
from
Birmingham, AL
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Greystone Medical Research, LLC
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Decatur Gastroenterology Associates
mi
from
Decatur, AL
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Decatur Gastroenterology Associates
mi
from
Decatur, AL
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Digestive Health Specialists of the Southeast
mi
from
Dothan, AL
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Digestive Health Specialists of the Southeast
mi
from
Dothan, AL
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
PrimeTeam
mi
from
Dothan, AL
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
PrimeTeam
mi
from
Dothan, AL
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Clinical Research Consultants, Inc.
mi
from
Hoover, AL
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Clinical Research Consultants, Inc.
mi
from
Hoover, AL
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Medical Affliated Research Center, Inc.
mi
from
Huntsville, AL
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Medical Affliated Research Center, Inc.
mi
from
Huntsville, AL
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Saadat Ansari MD LLC
mi
from
Huntsville, AL
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Saadat Ansari MD LLC
mi
from
Huntsville, AL
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Scottsboro Quick Care Clinic
mi
from
Scottsboro, AL
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Scottsboro Quick Care Clinic
mi
from
Scottsboro, AL
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Greater Arizona Gastroenterology Associates
mi
from
Casa Grande, AZ
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Greater Arizona Gastroenterology Associates
mi
from
Casa Grande, AZ
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Connect Clinical Research Center
mi
from
Chandler, AZ
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Connect Clinical Research Center
mi
from
Chandler, AZ
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Novara Clinical Research
mi
from
Phoenix, AZ
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Novara Clinical Research
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Digestive Health Research Unit
mi
from
Scottsdale, AZ
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Digestive Health Research Unit
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Genova Clinical Research
mi
from
Tucson, AZ
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Genova Clinical Research
mi
from
Tucson, AZ
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Adobe Clinical Research, LLC
mi
from
Tucson, AZ
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Adobe Clinical Research, LLC
mi
from
Tucson, AZ
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Acrc/Arizona Clinical Research Center, Inc.
mi
from
Tucson, AZ
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Acrc/Arizona Clinical Research Center, Inc.
mi
from
Tucson, AZ
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Visions Clinical Research - Tucson
mi
from
Tucson, AZ
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Visions Clinical Research - Tucson
mi
from
Tucson, AZ
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
W/C Clinical Research
mi
from
Tucson, AZ
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
W/C Clinical Research
mi
from
Tucson, AZ
Click here to add this to my saved trials
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated:  12/10/2012
Lynn Institute of the Ozarks
mi
from
Little Rock, AR
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Status: Enrolling
Updated: 12/10/2012
Lynn Institute of the Ozarks
mi
from
Little Rock, AR
Click here to add this to my saved trials